DIACEUTICS PLC (DXRX) — FY22 Results

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the DIACEUTICS PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and could be submitted at any time by the Q and A tab situated in the right hand corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question received in the meeting itself. However, the company will review your questions submitted today and publish responses where it is appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to Peter Keeling, CEO. Good afternoon, sir. Good afternoon, indeed, and good morning and good evening for those joining at different time zones. Nick and I are delighted to have the opportunity to present our 2022 results and discuss some significant progress that we've been making in the business over the last year and indeed talk a little bit about the outlook going forward. I I think one way to just book end 2022 for us was a lot a lot of moving parts. But I think for for 2022 overall, we made particularly strong financial progress. Nick will go into some detail on exactly what that looks like. And we were delighted to end the year ahead of initial market expectations. For those of you who have followed us know that a big part of our both innovation and our corporate engineering is to really shift to a subscription business model. We have some progress on that, update on that, and show you exactly what our direction of travel is there. Pleased to see that also made a took a major shift in 2022. Underpinning all of that, of course, is our platform, DXRX. We have a few slides, again, to illustrate what's actually happening on the platform, how are...